Market Size of Middle East And Africa Blood Glucose Monitoring Industry
Study Period | 2018 - 2029 |
Base Year For Estimation | 2023 |
Forecast Data Period | 2024 - 2029 |
Market Size (2024) | USD 4.34 Million |
Market Size (2029) | USD 6.51 Million |
CAGR (2024 - 2029) | > 8.55 % |
Major Players*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Middle East and Africa Blood Glucose Monitoring Market Analysis
The Middle East And Africa Blood Glucose Monitoring Market size is estimated at USD 4.34 million in 2024, and is expected to reach USD 6.51 million by 2029, growing at a CAGR of greater than 8.55% during the forecast period (2024-2029).
Diabetes and COVID-19 have a significant influence on public health not just overseas but also in the Middle East and Africa. In COVID-19 patients, diabetes has been reported to increase the incidence of both fatal infections and serious infections. Because diabetes is one of the primary health issues that is incredibly prevalent in the Middle East and African countries, the present research focused on understanding the epidemiology of COVID-19 in people with diabetes and the initiatives put in place by the governments to decrease its impact.
There is an increasing incidence of lifestyle diseases, such as diabetes, in developing countries that are increasing the demand for blood glucose monitoring devices. The increased awareness about healthcare facilities and preventive care is also supporting the growth of the market. The number of patients relying on self-monitoring blood glucose (SMBG) has increased. Owing to the high-cost constraints associated with continuous glucose monitoring (CGM), self-monitoring by glucometer is more acceptable in the Middle-East and Africa region. These devices help in the early detection of hypo and hyperglycemia conditions, which tend to drive the market for glucose monitoring.